Alantra advised Sangamo Therapeutics on the public tender offer followed by a squeeze-out on TxCell
SECTORHealthcare
ServiceM&A; Equity Capital Markets
Related Transactions
-
Dec 2024Corporate BrokerDec 2024SECTOR HealthcareService Corporate Broker; Equity Capital Markets
-
Oct 2024Sell-side advisoryOct 2024SECTOR HealthcareService M&A
-
Oct 2024Sell-side advisoryOct 2024SECTOR Consumer Goods & Retail; HealthcareService M&A
-
Oct 2024Sell-side advisoryOct 2024SECTOR Consumer Goods & Retail; HealthcareService M&A